Copenhagen, Denmark; November 15, 2004 – Genmab A/S (CSE: GEN) announced today that it is increasing its share capital by 7,405 shares as a consequence of the exercise of employee warrants. This increase is effected without any preemption rights for the existing shareholders of the company or others. All shares are subscribed in cash at a price of DKK 33.70 per share of nominally DKK 1 each. Proceeds to the company are approximately DKK 249,548.50 (approx. USD 43,500).

The new shares will be listed on the Copenhagen Stock Exchange after registration with the Danish Commerce and Companies Agency. Genmab A/S’ share capital will hereafter be DKK 29,752,363. The capital increase is expected to be finalized shortly.